Network Pharmacology Analysis Predicts that Borago Officinalis Constituents May Influence STING/TBK1/IRF3 Immune Signalling in Non-Small Cell Lung Cancer
Borago officinalis has been reported to contain numerous bioactive phytochemicals with anti-inflammatory and immunomodulatory effects; however, the ability of this herb to impact non-small cell lung cancer (NSCLC) and immunotherapy-related pathways is not well understood. In the present study, a network pharmacology ap...